fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

Health Canada approves COVID 19 AstraZeneca vaccine to prevent COVID-19

Written by | 17 Mar 2021

Health Canada has approved the Oxford-AstraZeneca COVID-19 vaccine (ChAdOx1 nCoV-19) and a related shot by the Serum Institute of India for use in Canada.

Update on the safety of COVID-19 Vaccine AstraZeneca

Written by | 16 Mar 2021

Following a recent concern raised around thrombotic events, AstraZeneca would like to offer its reassurance on the safety of its COVID-19 vaccine based on clear scientific evidence. Safety… read more.

EMA backs six new medicines

Written by | 14 Mar 2021

Article written by Gary Finnegan. The European Medicines Agency’s (EMA) human medicines committee (CHMP) recommended six medicines for approval at its February 2021 meeting:

International agencies coordinate regulation of COVID-19 vaccines and medicines

Written by | 13 Mar 2021

Article written by Gary Finnegan. Regulators around the globe are aligning their approaches to the approval of vaccines and medicines against COVID-19. Closer cooperation is seen as crucial… read more.

EMA plans rapid approval of vaccines against COVID-19 variants

Written by | 12 Mar 2021

Article written by Gary Finnegan. New COVID-19 vaccines against variants of the virus could be approved much more quickly than the first generation of jabs. The European Medicines… read more.

Fauci vs Kardashian: the public prefers health tips from experts

Written by | 11 Mar 2021

Article written by Gary Finnegan. People are more willing to reshare calls for social distancing if the message is endorsed by a well-known expert – such as US… read more.

COVID lockdown hits air ambulance services in remote Australia

Written by | 10 Mar 2021

Article written by Gary Finnegan. New data released by Australian researchers reveals the impact of the COVID-19 lockdown period on aeromedical retrievals in rural and remote regions. Researchers… read more.

Face masks reduced spread of COVID-19 during first wave

Written by | 9 Mar 2021

Article written by Gary Finnegan. Face masks likely played a role in reducing the spread of SARS-CoV-2 in Italy during the first half of 2020, according to a… read more.

Phase III study of Covaxin reports efficacy of 80.6% in COVID-19 – Ocugen/Bharat Biotech

Written by | 8 Mar 2021

Ocugen announced that its co-development partner, Bharat Biotech, announced the results of the first interim analysis of its Phase III study of Covaxin, a whole virion inactivated COVID-19… read more.

Drug treatment for the systemic inflammatory response in covid-19

Written by | 3 Mar 2021

Interview and article by Christine Clark Dr Mark Tomlin, consultant critical care pharmacist, describes how recent trial findings have identified effective treatments for the systemic inflammatory response syndrome… read more.

Understanding the systemic inflammatory response in covid-19

Written by | 2 Mar 2021

Interview and article by Christine Clark Although SARS-CoV-2 causes a mild illness in many people, some experience severe illness characterised by a systemic inflammatory response that can lead… read more.

Pfizer and BioNTech SE initiate a study as part of broad development plan to evaluate COVID 19 booster and new vaccine variants

Written by | 1 Mar 2021

Pfizer Inc.and BioNTech SE announced they have begun an evaluation of the safety and immunogenicity of a third dose of the Pfizer-BioNTech COVID-19 vaccine (BNT162b2) to understand the… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.